TY - JOUR
T1 - Role of Dopamine D1 and D2 Receptors in Novelty-Maintained Place Preference
AU - Bardo, M. T.
AU - Bowling, S. L.
AU - Robinet, P. M.
AU - Rowlett, J. K.
AU - Lacy, M.
AU - Mattingly, B. A.
PY - 1993/10
Y1 - 1993/10
N2 - Rats exposed to 1 of 2 different stimulus compartments showed a preference for the novel compartment. The novelty-maintained place preference was eliminated by the D1 agonist SKF 38393 and the D2 agonist quinpirole, but only at doses that also produced an impairment in locomotor activity. The novelty-maintained place preference was also eliminated by the D1 antagonist SCH 23390, but not by the D2 antagonist eticlopride. Both of the antagonist drugs tested produced a dose-dependent depression in locomotor activity. However, SCH 23390 was shown to block novelty-maintained place preference at a dose that had no significant effect on locomotor activity. These results indicate that D1 receptors may play a role in the incentive value of novel stimuli.
AB - Rats exposed to 1 of 2 different stimulus compartments showed a preference for the novel compartment. The novelty-maintained place preference was eliminated by the D1 agonist SKF 38393 and the D2 agonist quinpirole, but only at doses that also produced an impairment in locomotor activity. The novelty-maintained place preference was also eliminated by the D1 antagonist SCH 23390, but not by the D2 antagonist eticlopride. Both of the antagonist drugs tested produced a dose-dependent depression in locomotor activity. However, SCH 23390 was shown to block novelty-maintained place preference at a dose that had no significant effect on locomotor activity. These results indicate that D1 receptors may play a role in the incentive value of novel stimuli.
UR - http://www.scopus.com/inward/record.url?scp=0000401183&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0000401183&partnerID=8YFLogxK
U2 - 10.1037/1064-1297.1.1-4.101
DO - 10.1037/1064-1297.1.1-4.101
M3 - Article
AN - SCOPUS:0000401183
SN - 1064-1297
VL - 1
SP - 101
EP - 109
JO - Experimental and Clinical Psychopharmacology
JF - Experimental and Clinical Psychopharmacology
IS - 1-4
ER -